HomeCompareVLON vs JEPQ

VLON vs JEPQ: Dividend Comparison 2026

VLON yields 500.00% · JEPQ yields 11.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VLON wins by $61399.48M in total portfolio value
10 years
VLON
VLON
● Live price
500.00%
Share price
$0.40
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$61399.52M
Annual income
$44,063,578,515.70
Full VLON calculator →
JEPQ
JPMorgan Nasdaq Equity Premium Income ETF
● Live price
11.10%
Share price
$55.52
Annual div
$6.16
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$44.8K
Annual income
$2,152.59
Full JEPQ calculator →

Portfolio growth — VLON vs JEPQ

📍 VLON pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVLONJEPQ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VLON + JEPQ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VLON pays
JEPQ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VLON
Annual income on $10K today (after 15% tax)
$42,500.00/yr
After 10yr DRIP, annual income (after tax)
$37,454,041,738.34/yr
JEPQ
Annual income on $10K today (after 15% tax)
$943.83/yr
After 10yr DRIP, annual income (after tax)
$1,829.70/yr
At 15% tax rate, VLON beats the other by $37,454,039,908.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VLON + JEPQ for your $10,000?

VLON: 50%JEPQ: 50%
100% JEPQ50/50100% VLON
Portfolio after 10yr
$30699.78M
Annual income
$22,031,790,334.14/yr
Blended yield
71.77%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on VLON right now

VLON
Analyst Ratings
1
Buy
Consensus: Buy
Altman Z
36.7
Piotroski
2/9
JEPQ
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VLON buys
0
JEPQ buys
0
No recent congressional trades found for VLON or JEPQ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVLONJEPQ
Forward yield500.00%11.10%
Annual dividend / share$2.00$6.16
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$61399.52M$44.8K
Annual income after 10y$44,063,578,515.70$2,152.59
Total dividends collected$59892.67M$16.3K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: VLON vs JEPQ ($10,000, DRIP)

YearVLON PortfolioVLON Income/yrJEPQ PortfolioJEPQ Income/yrGap
1← crossover$60,700$50,000.00$11,930$1,110.39+$48.8KVLON
2$348,594$283,644.86$14,133$1,224.34+$334.5KVLON
3$1,895,372$1,522,376.89$16,632$1,340.46+$1.88MVLON
4$9,763,990$7,735,942.00$19,454$1,457.97+$9.74MVLON
5$47,691,977$37,244,507.54$22,626$1,576.08+$47.67MVLON
6$221,049,019$170,018,603.23$26,175$1,694.09+$221.02MVLON
7$972,993,924$736,471,474.07$30,133$1,811.32+$972.96MVLON
8$4,070,762,075$3,029,658,575.98$34,531$1,927.17+$4070.73MVLON
9$16,201,818,371$11,846,102,950.68$39,403$2,041.08+$16201.78MVLON
10$61,399,524,173$44,063,578,515.70$44,787$2,152.59+$61399.48MVLON

VLON vs JEPQ: Complete Analysis 2026

VLONStock

Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The company is also developing ADMIR, an abuse deterrent formulation of methylphenidate for the treatment of ADHD. Vallon Pharmaceuticals, Inc. was incorporated in 2018 and is based in Philadelphia, Pennsylvania.

Full VLON Calculator →

JEPQETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →
📬

Get this VLON vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VLON vs SCHDVLON vs JEPIVLON vs OVLON vs KOVLON vs MAINVLON vs XYLDVLON vs QYLDVLON vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.